Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 2460-2462, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arenas, J.
Right arrow Articles by Culebras, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arenas, J.
Right arrow Articles by Culebras, J. M.

Clinical Chemistry, Vol 34, 2460-2462, Copyright © 1988 by American Association for Clinical Chemistry

Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders

J Arenas, V Diaz, G Liras, E Gutierrez, I Santos, A Martinez and JM Culebras
Servicios de Bioquimica y Neurologia, Hospital 1 de Octubre, Madrid, Spain.

We studied possible correlations between anatomopathological and clinical features and the values for total creatine kinase (CK; EC 2.7.3.2) and its isoenzymes, including the proportion of CK-MB, in a population displaying several neuromuscular pathologies. Although we observed no specific isoenzyme pattern associated with the different myopathies, we found isoenzyme analysis useful in studying the histopathological evolution of illness. We also considered whether the pathology was regenerative or nonregenerative, and what type of fiber (I or II) was involved. High CK-MB percentages (greater than 6%) were associated with regenerative and type I fiber myopathies, with regenerative type tissues being the principal factor associated with an increasing proportion of CK-MB. Studying the changes in CK-MB percentage in serum appears to be useful in discriminating neuromuscular from myocardial pathologies.


The following articles in journals at HighWire Press have cited this article:


Home page
 NeurologyHome page
G. M. Pasinetti, L. H. Ungar, D. J. Lange, S. Yemul, H. Deng, X. Yuan, R. H. Brown, M. E. Cudkowicz, K. Newhall, E. Peskind, et al.
Identification of potential CSF biomarkers in ALS
Neurology, April 25, 2006; 66(8): 1218 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Hammerer-Lercher, P. Erlacher, R. Bittner, R. Korinthenberg, D. Skladal, S. Sorichter, W. Sperl, B. Puschendorf, and J. Mair
Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy
Clin. Chem., March 1, 2001; 47(3): 451 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
P D W KIELY, F E BRUCKNER, J A NISBET, and A DAGHIR
Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I
Ann Rheum Dis, September 1, 2000; 59(9): 750 - 750.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.